Henry Schein, Inc. HSIC

86.37 0.84 0.98% as of 25 Sep
Market cap
$9.5B
P/E
25.0×
Indexes indicate stock being part of an index,
Insider Buys alert about insiders buying in the last 12 month

Henry Schein, Inc. (HSIC) P/S ratio

As of 25 September 2026, Henry Schein, Inc. (HSIC) trades at a P/S ratio of 0.7×. Over the past ten years it has ranged from 0.6× (October 2025) to 1.6× (December 2018); the current reading is higher than 18% of that period. That is above the Medical Distribution industry median of 0.2× and below the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 0.7× 0.04%
FY2024 0.7× (13.45%)
FY2023 0.8× (6.60%)
FY2022 0.9× (2.22%)
FY2021 0.9× (6.99%)
FY2020 0.9× (4.66%)
FY2019 1.0× (1.06%)
FY2018 1.0× 0.91%
FY2017 1.0× 15.80%
FY2016 0.9× (11.66%)

Quarterly

Period P/S ratio Change
Jun 2026 0.7× 10.06%
Mar 2026 0.6× (8.62%)
Dec 2025 0.7× 12.33%
Sep 2025 0.6× (11.57%)
42 more quarters

Against its own ten years

Low 0.6× High 1.6×
Ten-year median 0.9×
Current reading's percentile 18

P/S ratio against peers

Company P/S ratio
YI 111, Inc. Sponsored ADR compare 0.0×
ACH Accendra Health, Inc. compare 0.0×
COR Cencora, Inc. compare 0.2×
CAH Cardinal Health, Inc. compare 0.2×
MCK McKesson Corporation compare 0.3×
COSM Cosmos Health Inc. compare 0.3×
HSIC Henry Schein, Inc. 0.7×
AHG Akso Health Group Sponsored ADR compare 0.9×
FOCL FocalTherics compare 2.2×
Medical Distribution industry median 0.2×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on HSIC